Actuate Therapeutics Inc
(ACTU)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,925 | 6,493 | 3,889 | 8,642 | 13,524 |
| TOTAL | $17,444 | $6,689 | $4,249 | $9,208 | $14,263 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 270 | 280 | 235 | 111 | 0 |
| TOTAL | $270 | $280 | $235 | $111 | $N/A |
| Total Assets | $17,714 | $6,969 | $4,483 | $9,318 | $14,263 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,245 | 3,171 | 2,644 | 1,921 | 2,330 |
| Accrued Expenses | 868 | 1,459 | 1,309 | 959 | 71 |
| TOTAL | $6,373 | $9,201 | $9,154 | $8,803 | $8,497 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 405 | 422 | 417 | 412 | 407 |
| TOTAL | $405 | $422 | $417 | $412 | $407 |
| Total Liabilities | $6,778 | $9,623 | $9,571 | $9,214 | $8,904 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 23,243 | 20,745 | 19,620 | 19,532 | 19,532 |
| Retained earnings | -150,054 | -144,646 | -138,697 | -132,380 | -125,934 |
| TOTAL | $10,936 | $-2,654 | $-5,088 | $104 | $5,359 |
| Total Liabilities And Equity | $17,714 | $6,969 | $4,483 | $9,319 | $14,263 |